Non-hormonal compositions and methods for male contraception
AssigneePharmajor International
InventorsGuillaume El Glaoui, Mehdi El Glaoui, Philippe Perrin, Stéphane Droupy, Véronique Agathon-Meriau
Life of this patent
Estimating the term…
Loading patent…
AssigneePharmajor International
InventorsGuillaume El Glaoui, Mehdi El Glaoui, Philippe Perrin, Stéphane Droupy, Véronique Agathon-Meriau
Estimating the term…
The present invention relates to non-hormonal compositions and methods for inducing a condition of aspermia, azoospermia, or severe oligozoospermia in the male subject such that these compositions and methods for administering the same may be used as male contraception. Embodiments of the present invention may comprise a composition comprising an alpha-1-adrenoreceptor antagonist, such as (R)-silodosin, for daily administration to a male subject. The compositions and related methods may further include pharmaceutically acceptable carriers. The present invention further includes formulations which allow for a delay such that delayed or missed dose(s) do not nullify the contraceptive effect of the treatment regimen. Such compositions and methods may also avoid the side effects associated with typical formulations of alpha-1-adrenoreceptor antagonists.
A method for reversible, continuous non-hormonal contraception in a male subject, the method comprising administering once daily at about the same time, a dose of a composition comprising:
A method for reversible, continuous non-hormonal contraception in a male subject, the method comprising administering once daily at about the same time, a dose of a composition comprising:
A method for reversible, continuous non-hormonal contraception in a male subject, the method comprising administering once daily at about the same time, a dose of a composition comprising:
Dependencies are inferred from the claim text.